COPE Healthcare Consulting, Inc. – Trademark Portfolio
Entity Type: 03
COPE Healthcare Consulting, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include COPE HEALTH SOLUTIONS. The owner is based in Los Angeles, CA.
1150 South Olive Street, Suite 1200
Los Angeles, CA 90015
Showing of trademarks Trademarks
Trademark Classifications
COPE Healthcare Consulting, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does COPE Healthcare Consulting, Inc. have?
COPE Healthcare Consulting, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does COPE Healthcare Consulting, Inc. file in?
COPE Healthcare Consulting, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are COPE Healthcare Consulting, Inc.'s most well-known trademarks?
COPE Healthcare Consulting, Inc.'s registered trademark portfolio includes well-known marks such as COPE HEALTH SOLUTIONS. These are among 1 currently registered trademark in the portfolio.
What is COPE Healthcare Consulting, Inc.'s trademark registration success rate?
COPE Healthcare Consulting, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.